Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation 

The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK’s competitiveness for global clinical research. 

Follow this news feed: